General Psychiatry - Articles - Page 154

Two New Meta-Analyses Compare Antidepressants

March 1, 2009

Section editor, Glen Spielmans, PhD. Dr. Spielmans has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.

Two recent meta-analyses compared second-generation antidepressants (SGADs) to each other regarding efficacy and safety.

EXPERT Q&A

The Neurobiology of Schizophrenia

March 1, 2009

Fredrik Jarskog, MD

Fredrik Jarskog, MD. Associate Professor of Clinical Psychiatry, Chief of Clinical Therapeutics Lieber Center for Schizophrenia Research and Treatment New York State Psychiatric Institute/Columbia University.

Dr. Jarskog has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity. Dr. Jarskog has disclosed that glycine, D-serine, D-cycloserine, and Glu2/3 receptor agonists are not FDA-approved for the treatment of schizophrenia.

Dr. Jarskog, for many years the dopamine theory of schizophrenia has been dominant in the field. What is the current status of that theory?

Learning Objectives, Antipsychotic Roundup 2009, TCPR, March 2009

March 1, 2009

After reading these articles, you should be able to…

Psychotropics and Pregnancy: An Update

February 1, 2009

Daniel Carlat, MD

On May 28, 2008, The Food and Drug Administration announced a major revision in the labeling of the pregnancy and breast-feeding risk of drugs. The current labeling system was devised in 1979 and has been criticized over the years for being confusing and for failing to incorporate the most recent data.

Breast Feeding and Psychiatric Medications: An Overview

February 1, 2009

Dhwani Shah, MD

Any discussion of psychiatric medications and breastfeeding must begin with the benefits of breastfeeding, which are substantial. While all psychotropic medications enter the breast milk, medication exposure for a nursing infant is much less than the exposure to a fetus during pregnancy.

Risperidone Shows Mixed Results in Augmenting Antidepressant Treatment

February 1, 2009

Section editor, Glen Spielmans, PhD

A recent trial examined the impact of augmenting antidepressant treatment with risperidone. Participants had not shown a treatment response after taking an antidepressant for at least five weeks, and were then randomly assigned to receive either risperidone or placebo augmentation along with the same dose of their antidepressant.

Headache Is a Risk Factor For Suicidality

February 1, 2009

John O’Reardon, MD

The original Epidemiological Catchment Area (ECA) study (based on interviews conducted in the 1980s) examined the prevalence of mental disorders among adults in five American cities. Taking a fresh look, researchers examined data from 6,832 adults who resided in the community in order to ascertain the relationship between headache and suicidality.

Adverse Effects of SSRIs in Pregnancy

February 1, 2009

Dr. Hendrick, earlier this decade, most experts felt that SSRIs were relatively safe in pregnancy, but lately the pendulum seems to be swinging in the other direction. What do you consider to be the major risks of SSRIs in pregnancy?

Learning Objectives, Psychiatric Medication in Pregnancy and Lactation, TCPR, February 2009

February 1, 2009

After reading these articles, you should be able to…

Transcranial Magnetic Stimulation is Approved. Now What?

January 1, 2009

Daniel Carlat, MD

One year ago we reviewed the status of transcranial magnetic stimulation for depression, and concluded with the following TCPR Verdict: “TMS for depression: Approval is highly unlikely.” We were wrong.

General Psychiatry
RSS

Two New Meta-Analyses Compare Antidepressants

The Neurobiology of Schizophrenia

Learning Objectives, Antipsychotic Roundup 2009, TCPR, March 2009

Psychotropics and Pregnancy: An Update

Breast Feeding and Psychiatric Medications: An Overview

Risperidone Shows Mixed Results in Augmenting Antidepressant Treatment

Headache Is a Risk Factor For Suicidality

Adverse Effects of SSRIs in Pregnancy

Learning Objectives, Psychiatric Medication in Pregnancy and Lactation, TCPR, February 2009

Transcranial Magnetic Stimulation is Approved. Now What?

Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

A More Powerful Antidepressant

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

About

Shop Online

Newsletters

Contact

Follow Us

General Psychiatry RSS

About

Shop Online

Newsletters

Contact

Follow Us

General Psychiatry
RSS